Injective (INJ) is currently priced at $2.80, reflecting a minor decline of 0.36% over the past 24 hours. The daily trading range has been narrow, with a high of $2.82 and a low of $2.78, indicating a lack of volatility in the short term.

Trading volume stands at approximately 26.4 million, representing 9.44% of the market cap, which suggests moderate interest from traders. The hourly moving averages show mixed signals, with the 8 SMA slightly down and the 144 SMA indicating a more significant decline of 1.45%, pointing to potential bearish sentiment.

The Relative Strength Index (RSI) for the last hour is at 51, while the 7-day RSI is neutral at 50, suggesting neither overbought nor oversold conditions. However, the longer-term RSIs show bearish trends, with a 14-day price change of -9.73% and a 30-day change of -9.71%, indicating a downward trajectory.

The all-time high for INJ was $52.62, reached on March 14, 2024, which highlights the significant distance from current prices and suggests substantial market volatility historically. Given the current technical indicators and the negative price trends, the market sentiment appears cautious.

In conclusion, despite the recent stability in price, the overall trend and volume metrics suggest a bearish outlook. Therefore, the rating for Injective (INJ) is a Sell, as the risks of further declines outweigh potential short-term gains.